«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:

第5卷

期数:

2012年07期

页码:

556-0

栏目:

综述

出版日期:

2012-07-06

文章信息/Info

Title:

Advances in pharmacological function of Carthamus tinctorius and its essential constitutes

作者:

陈梦; 赵丕文; 孙艳玲; 孙丽萍;

Author(s):

CHEN Meng; ZHAO Pi-wen; SUN Yan-ling; et al.

School of Basic Medical Sciences, Beijing University of Chinese Medicine,Beijing 100029,China

关键词:

红花;  红花黄色素;  羟基红花黄色素A;  药理作用;  心脑血管疾病

Keywords:

Carthamus tinctorius L;  Safflor yellow;  Hydroxyl-safflor yellow A;  Pharmacology function;  Cardio-cerebrovascular diseases

分类号:

R285.5

DOI:

-

文献标志码:

A

摘要:

红花为活血化瘀的经典中药之一,其供药记载最早见于汉代张仲景的《金匮要略》,常用于治疗高血压、冠心病、脑血栓等疾病。目前,国内外学者对红花及其主要成分红花黄色素、羟基红花黄色素A等在抗脑缺血、抗心肌损伤、抗血栓、抗氧化、抗细胞凋亡、抗炎、抗肿瘤等方面的药理效应和作用机制进行了广泛而深入的研究,为红花的临床应用提供了依据。本文通过查阅相关文献资料,对红花及其主要成分的药理作用研究进行综述,以期为相关领域科研工作者的理论研究、药物的临床应用及新药开发提供参考。

Abstract:

Carthamus tinctorius L. is a traditional Chinese medicine promoting blood circulation and removing blood stasis. It was first found in Synopsis of Formulae from the Golden Chamber written by Zhang zhong-jing, Han dynasty. It has been commonly used to treat many kinds of diseases such as high blood pressure, coronary heart disease and cerebral thrombosis. At present, international and domestic academics have done lots of research works concerning about the pharmacological action and its mechanism of Carthamus tinctorius L and its two essential constitutes: safflor yellow and Hydroxyl-safflor yellow A in the field of anti-ischemic injury, anti-myocardial injury, anti-thrombus function, anti-oxidation, anti-apoptosis, anti-inflammation and anti-tumor. By referring to a large number of literature and information, we summarized the pharmacological function of Carthamus tinctorius L and its essential constitutes. We expect this review will be helpful to future scientific research, clinical application and new drug development.Carthamus tinctorius L. is a traditional Chinese medicine promoting blood circulation and removing blood stasis. It was first found in Synopsis of Formulae from the Golden Chamber written by Zhang zhong-jing, Han dynasty. It has been commonly used to treat many kinds of diseases such as high blood pressure, coronary heart disease and cerebral thrombosis. At present, international and domestic academics have done lots of research works concerning about the pharmacological action and its mechanism of Carthamus tinctorius L and its two essential constitutes: safflor yellow and Hydroxyl-safflor yellow A in the field of anti-ischemic injury, anti-myocardial injury, anti-thrombus function, anti-oxidation, anti-apoptosis, anti-inflammation and anti-tumor. By referring to a large number of literature and information, we summarized the pharmacological function of Carthamus tinctorius L and its essential constitutes. We expect this review will be helpful to future scientific research, clinical application and new drug development.

参考文献/References:

[1] 国家药典委员会.中国药典(2005年版)[S].I部.2005:103-104.
[2] Yang Y, Wu W, Zheng Y L. Advances in studies on safflower(Carthamus tinctorius L. )[J].J Sichuan Agricu Univ,2004,22(4):365-369.
[3] Takahashi Y,Miyassaka N, Tasaka SH,et al.Constitution of two coloting matters in the flower petals of carthamus tinctorius L[J].Tetrahedron Lett,1982,23(49):5163-5165.
[4] Takahashi Y, Satio K, Yanagiya,et al. Chemical constitution of safior yellow B. quinochalcone C-glycoside from the flower petals of carthamus tinctorius L[J].Tetrahedron Lett,1984,25(23):2471-2472.
[5] Meselhy MR,Kadota S,Momose Y,et al.Two new quinochalcone yellow pigments from Carthamus tinctorius and Ca²⁺antagonistic activity of tinctormine[J].Chem Pharm Bull,1993,41(10):1796-1798.
[6] 范莉,濮润,赵海誉,等.红花抗ADP诱导的血小板聚集活性研究[J].中国中药杂志,2011,36(9):1242-1244.
[7] 赵金明,秦文艳,齐越,等.红花黄色素抗凝血作用及对血小板聚集影响的研究[J].实验动物科学,2009,26(6):30-32.
[8] 岳海涛,李金成,吕铭洋,等.红花注射液对大鼠血栓形成的影响及作用机制[J].中草药,2011,42(8):1585-1587.
[9] 蒋旭宏,黄小民.红花注射液对急性肝损伤大鼠抗氧化作用的实验研究[J].中华中医药学刊,2010,28(4):832-834.
[10] 卜志勇,郑玲,李安军,等.红花黄素对大鼠脊髓损伤局部SOD、MDA和细胞凋亡的影响[J].湖北医药学院学报,2011,30(1):23-25,封4.
[11] 金鸣,李金荣,吴伟,等.羟基红花黄色素A抗氧化作用的研究[J].中草药,2004,35(6):665-666.
[12] Le-qun Shan, Sai Ma, Xiu-chun Qiu,et al. Hydroxysafflor Yellow A protects spinal cords from ischemia/reperfusion injury in rabbits[J]. BMC Neuroscience, 2010,11:98-105.
[13] 彭其胜.红花注射液对大鼠周围神经缺血再灌注损伤的保护作用及其机制研究[J].中国药房,2011,(23):2139-2141.
[14] 夏玉叶,闵旸,盛雨辰,等.羟基红花黄色素A对大鼠脑缺血损伤的神经保护作用[J].中国医药工业杂志,2005,36(12):760-762.
[15] 盛雨辰,夏玉叶,闵旸,等.羟基红花黄色素A对局灶性脑缺血后大鼠脑组织诱导型一氧化氮合酶的影响[J].中国药理学通报,2006,22(9):1134-1137.
[16] 陈亭亭,杜玉娟,刘晓雷,等.羟基红花黄色素A对脑缺血大鼠皮层炎症信号转导途径相关因子的抑制作用[J].药学学报,2008,43(6):570-575.
[17] 张庆,郑冬雁,徐红岩,等.红花黄素对大鼠局灶性脑缺血再灌注损伤的保护作用[J].山东大学学报(医学版),2011,49(6):11-14.
[18] Wei X, Liu H, Sun X,et al.Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action[J].Neurosci Lett,2005,386(1):58-62.
[19] 吴伟,李金荣,朴永哲,等.羟基红花黄色素A缓解大鼠心肌线粒体损伤的作用研究[J].中国药学杂志,2006,41(16):1225-1227.
[20] He H, Yang X, Shi M, et al. Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats[J].J Pharm Pharmacol,2008,60(1):115-123.
[21] 张团笑,敬华娥,买文丽,等.红花注射液降低家兔动脉血压的机制研究[J].时珍国医国药,2010,21(1):138-139.
[22] 聂培鹤,张文慧,金珠,等.羟基红花黄色素对离体心脏功能的影响[J].上海交通大学学报(医学版),2010,30(5):540-543.
[23] 靳宏光,姜琛,田宇丹.羟基红花黄色素A对兔动脉粥样硬化影响的实验研究[J].上海中医药杂志,2011,45(4):67-68.
[24] 张琳,沈国舜,张镜年,等.羟基红花黄色素A的血管作用及研究机制[J].上海交通大学学报(医学版),2011,29(4):431-434.
[25] 徐万群,石磊,顾华丽,等.红花黄色素对急性冠状动脉综合征病人炎症因子的影响[J].青岛大学医学院学报,2011,47(5):426-428.
[26] 王晓菲,金鸣,童静,等.羟基红花黄色素A对油酸-脂多糖所致大鼠急性肺损伤的保护作用[J].药学学报.2010,45(7):940-944.
[27] 张建初,夏蕾,白明,等.实验性大鼠肺血栓栓塞症中ICAM-1、P-选择素的变化及红花注射液对其的影响[J].中国中西医结合杂志,2006,26(7):629-632.
[28] 吴伟,金鸣,童静,等.羟基红花黄色素A诱导家兔白细胞活化的作用[J].药学学报,2011,46(2):153-157.
[29] 金鸣,裴崇强,臧宝霞,等.羟基红花黄色素A缓解血小板激活因子诱导的内皮细胞炎症因子表达升高作用的研究[J].心肺血管病杂志,2011,30(5):429-432.
[30] Kasahars Y, Kumaki K, Katagiri S, et al. Flos Carthami extract and its component, stigmasterol, inhibit tumor promotion in mouse skin two - stage carcinogenesis[J]. Phytother Res,1994,8:327-331.
[31] 韩海玲,孙玉芹,宋文刚,等.红花黄色素对内皮细胞增殖及凋亡的保护作用[J].中国实验诊断学,2011,15(1):51-54.
[32] 张前,牛欣,闫妍,等.羟基红花黄色素A抑制新生血管形成的机制研究[J].北京中医药大学学报,2004,27(3):25-29.
[33] 张前,牛欣,闫妍,等.羟基红花黄色素A对体外培养人脐静脉内皮细胞增殖的抑制作用[J].中国医药学报,2004,19(6):379-381.

相似文献/References:

备注/Memo

备注/Memo:

基金项目:北京中医药大学自主科研课题(JBYZZ-JS014); 北京中医药大学创新团队项目(2011CXTD-07)
作者单位：100029 北京中医药大学基础医学院[陈梦(硕士研究生)、赵丕文、孙艳玲(硕士研究生)、孙丽萍]
作者简介：陈梦(1988- ),女,2010级硕士在读研究生。研究方向:红花的植物雌激素样作用及其机理。E-mail:chenmeng1031@163.com
通讯作者：赵丕文(1967- ),女,博士,教授,硕士生导师。研究方向:妇科常用中药药理作用机制。E-mail:pwzhao@sina.com

常用功能

更新日期/Last Update: 1900-01-01